A crucial element of regenerative medicine and drug discovery lies in the ability to multiply human stem cell populations to sufficient quantities for therapeutic uses. Traditionally, restricted cell supply posed a significant hindrance to advancement in these fields. Consequently, considerable effort has been directed towards enhancing procedures